Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2025-07-31 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2025-07-31 English
Dividend
Regulatory Filings
2025-07-31 English
Outcome of Board Meeting
Regulatory Filings
2025-07-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about a revised invitation for an upcoming earnings conference call for Q1 FY26. It includes details about the call, such as date, time, participants, and dial-in information. The document does not contain actual financial results or detailed financial statements but is an announcement related to the earnings call event. According to the classification rules, such documents that announce or invite to earnings calls without containing the transcript or financial data themselves should be classified as Call Transcript (CT) only if they contain the full transcript. Since this is only an invitation and not the transcript, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement under SEBI regulations about the earnings call event. The document length is about 5955 characters, which is not a full report but an announcement. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2025-07-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an invitation and intimation for an earnings conference call scheduled for Q1 FY26. It mentions the date and time of the call, the management participants, and instructions for joining the call. It does not contain any actual financial results or substantive financial data, only an announcement of the upcoming call where such results will be discussed. The document is about the earnings conference call itself, not the earnings release or the transcript of the call. Therefore, the appropriate classification is 'Call Transcript' (CT) because it relates to the earnings conference call event, but since it is only an invitation and not the transcript, the best fit is CT as it is the category for conference call related documents. Confidence is high as the document clearly states it is an invitation for the earnings call and does not contain financial results or other report types.
2025-07-24 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-24 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.